Home › Companies › HERON THERAPEUTICS INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and HERON THERAPEUTICS INC.’s Form 8-K, filed June 18, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 13, 2024: 11 items on HERON THERAPEUTICS INC.’s Form 8-K, filed June 18, 2024: 11 passed (calculated).
Significant dissent: 1 equity or compensation plan (28.0% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025 2025-2026
Activist investors: Rubric Capital (13D, 15.9%, as of October 17, 2025) · Clearline Capital (13F, 5.8%, as of September 30, 2026) · Tang Capital (13F, 4.7%, as of September 30, 2026)
Explore HERON THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are HERON THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 18, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Mr. Collard | 87,052,188 | 622,098 | 1,794,705 | -- | 29,159,734 | 99.3% | Passed (calculated) | — |
| Elect Director: Dr. Dissanaike | 86,622,579 | 875,337 | 1,971,075 | -- | 29,159,734 | 99% | Passed (calculated) | — |
| Elect Director: Mr. Johnson | 86,610,323 | 864,346 | 1,994,322 | -- | 29,159,734 | 99.0% | Passed (calculated) | — |
| Elect Director: Mr. Morgan | 86,819,401 | 667,561 | 1,982,029 | -- | 29,159,734 | 99.2% | Passed (calculated) | — |
| Elect Director: Ms. Rodriguez | 86,593,635 | 879,793 | 1,995,563 | -- | 29,159,734 | 99% | Passed (calculated) | — |
| Elect Director: Mr. Waage | 86,762,924 | 711,926 | 1,994,141 | -- | 29,159,734 | 99.2% | Passed (calculated) | — |
| 2. Ratification of the appointment of Withum Smith+Brown, PC as the Company's independent registered public accounting firm for the year ending December 31, 2024 | 114,364,367 | 358,527 | 3,905,831 | -- | 0 | 99.7% | Passed (calculated) | — |
| 3. Nonbinding advisory vote to approve compensation paid to the Company's Named Executive Officers during the year ended December 31, 2023 | 72,711,988 | 14,427,205 | 2,329,798 | -- | 29,159,734 | 83% | Passed (calculated) | — |
| 4. Amendment to the Company's Certificate of Incorporation, as amended, to increase the aggregate number of authorized shares of the Company's common stock by 175,000,000 from 225,000,000 to 400,000,000 | 104,392,527 | 11,372,028 | 2,864,170 | -- | 0 | 90% | Passed (calculated) | — |
| 5. Amendment to the Company's 2007 Amended and Restated Equity Incentive Plan to increase the number of shares of the Company's common stock authorized for issuance thereunder by 7,500,000 from 39,190,000 to 46,690,000 | 62,949,448 | 24,467,411 | 2,052,132 | -- | 29,159,734 | 72% | Passed (calculated) | — |
| 6. Amendment to the Company's 1997 Employee Stock Purchase Plan, as amended, to increase the number of shares of the Company's common stock authorized for issuance thereunder by 1,200,000 from 2,225,000 to 3,425,000 | 82,707,274 | 5,000,632 | 1,761,085 | -- | 29,159,734 | 94% | Passed (calculated) | — |
Source: HERON THERAPEUTICS INC., Form 8-K, filed with the SEC on June 18, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
160 asset managers disclosed a vote on at least one HERON THERAPEUTICS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Description as filed by funds: To elect six director nominees to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Adam Morgan
HERON THERAPEUTICS INC.’s own tally for this item (“Elect Director: Mr. Morgan”): 86,819,401 for, 667,561 against, per its Form 8-K filed June 18, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 42 asset managers below reported 12,610,374 for, 34,692 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,357,334 | 0 | 0 | 0 | For |
| BlackRock | 2,600,053 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,632,692 | 0 | 0 | 0 | For |
| State Street | 582,775 | 0 | 0 | 0 | For |
| Charles Schwab | 502,940 | 0 | 0 | 0 | For |
| Equitable | 274,608 | 0 | 0 | 0 | For |
| SEI | 240,911 | 0 | 0 | 0 | For |
| HIGHLAND GLOBAL ALLOCATION FUND | 232,800 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 224,108 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 185,313 | 0 | 0 | 0 | For |
| Lincoln Financial | 134,700 | 0 | 0 | 0 | For |
| TIAA | 116,628 | 0 | 0 | 0 | For |
| Fidelity | 93,989 | 0 | 0 | 0 | For |
| Federated Hermes | 47,993 | 0 | 0 | 0 | For |
| Northern Trust | 46,803 | 0 | 0 | 0 | For |
| Zacks Trust | 41,348 | 0 | 0 | 0 | For |
| AuguStar | 0 | 0 | 34,692 | 0 | Abstain |
| Pacific Life | 33,105 | 0 | 0 | 0 | For |
| Voya | 32,333 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,518 | 0 | 0 | 0 | For |
| Legg Mason | 21,926 | 0 | 0 | 0 | For |
| John Hancock | 19,729 | 0 | 0 | 0 | For |
| Brighthouse | 19,319 | 0 | 0 | 0 | For |
| AQR | 19,191 | 0 | 0 | 0 | For |
| Victory Capital | 18,762 | 0 | 0 | 0 | For |
Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Description as filed by funds: To elect six director nominees to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Christian Waage
HERON THERAPEUTICS INC.’s own tally for this item (“Elect Director: Mr. Waage”): 86,762,924 for, 711,926 against, per its Form 8-K filed June 18, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 42 asset managers below reported 12,603,246 for, 7,128 against, 34,692 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,357,334 | 0 | 0 | 0 | For |
| BlackRock | 2,600,053 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,632,692 | 0 | 0 | 0 | For |
| State Street | 582,775 | 0 | 0 | 0 | For |
| Charles Schwab | 502,940 | 0 | 0 | 0 | For |
| Equitable | 274,608 | 0 | 0 | 0 | For |
| SEI | 240,911 | 0 | 0 | 0 | For |
| HIGHLAND GLOBAL ALLOCATION FUND | 232,800 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 224,108 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 185,313 | 0 | 0 | 0 | For |
| Lincoln Financial | 134,700 | 0 | 0 | 0 | For |
| TIAA | 116,628 | 0 | 0 | 0 | For |
| Fidelity | 93,989 | 0 | 0 | 0 | For |
| Federated Hermes | 47,993 | 0 | 0 | 0 | For |
| Northern Trust | 46,803 | 0 | 0 | 0 | For |
| Zacks Trust | 41,348 | 0 | 0 | 0 | For |
| AuguStar | 0 | 0 | 34,692 | 0 | Abstain |
| Pacific Life | 33,105 | 0 | 0 | 0 | For |
| Voya | 32,333 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,518 | 0 | 0 | 0 | For |
| Legg Mason | 21,926 | 0 | 0 | 0 | For |
| John Hancock | 19,729 | 0 | 0 | 0 | For |
| Brighthouse | 19,319 | 0 | 0 | 0 | For |
| AQR | 19,191 | 0 | 0 | 0 | For |
| Victory Capital | 18,762 | 0 | 0 | 0 | For |
Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Description as filed by funds: To elect six director nominees to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Craig Collard
HERON THERAPEUTICS INC.’s own tally for this item (“Elect Director: Mr. Collard”): 87,052,188 for, 622,098 against, per its Form 8-K filed June 18, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 42 asset managers below reported 12,610,374 for, 34,692 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,357,334 | 0 | 0 | 0 | For |
| BlackRock | 2,600,053 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,632,692 | 0 | 0 | 0 | For |
| State Street | 582,775 | 0 | 0 | 0 | For |
| Charles Schwab | 502,940 | 0 | 0 | 0 | For |
| Equitable | 274,608 | 0 | 0 | 0 | For |
| SEI | 240,911 | 0 | 0 | 0 | For |
| HIGHLAND GLOBAL ALLOCATION FUND | 232,800 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 224,108 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 185,313 | 0 | 0 | 0 | For |
| Lincoln Financial | 134,700 | 0 | 0 | 0 | For |
| TIAA | 116,628 | 0 | 0 | 0 | For |
| Fidelity | 93,989 | 0 | 0 | 0 | For |
| Federated Hermes | 47,993 | 0 | 0 | 0 | For |
| Northern Trust | 46,803 | 0 | 0 | 0 | For |
| Zacks Trust | 41,348 | 0 | 0 | 0 | For |
| AuguStar | 0 | 0 | 34,692 | 0 | Abstain |
| Pacific Life | 33,105 | 0 | 0 | 0 | For |
| Voya | 32,333 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,518 | 0 | 0 | 0 | For |
| Legg Mason | 21,926 | 0 | 0 | 0 | For |
| John Hancock | 19,729 | 0 | 0 | 0 | For |
| Brighthouse | 19,319 | 0 | 0 | 0 | For |
| AQR | 19,191 | 0 | 0 | 0 | For |
| Victory Capital | 18,762 | 0 | 0 | 0 | For |
Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
Description as filed by funds: To elect six director nominees to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Craig Johnson
HERON THERAPEUTICS INC.’s own tally for this item (“Elect Director: Mr. Johnson”): 86,610,323 for, 864,346 against, per its Form 8-K filed June 18, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 42 asset managers below reported 12,561,961 for, 48,413 against, 34,692 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,357,334 | 0 | 0 | 0 | For |
| BlackRock | 2,600,053 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,632,692 | 0 | 0 | 0 | For |
| State Street | 582,775 | 0 | 0 | 0 | For |
| Charles Schwab | 502,940 | 0 | 0 | 0 | For |
| Equitable | 274,608 | 0 | 0 | 0 | For |
| SEI | 240,911 | 0 | 0 | 0 | For |
| HIGHLAND GLOBAL ALLOCATION FUND | 232,800 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 224,108 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 185,313 | 0 | 0 | 0 | For |
| Lincoln Financial | 134,700 | 0 | 0 | 0 | For |
| TIAA | 116,628 | 0 | 0 | 0 | For |
| Fidelity | 93,989 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 47,993 | 0 | 0 | Against |
| Northern Trust | 46,803 | 0 | 0 | 0 | For |
| Zacks Trust | 41,348 | 0 | 0 | 0 | For |
| AuguStar | 0 | 0 | 34,692 | 0 | Abstain |
| Pacific Life | 33,105 | 0 | 0 | 0 | For |
| Voya | 32,333 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,518 | 0 | 0 | 0 | For |
| Legg Mason | 21,926 | 0 | 0 | 0 | For |
| John Hancock | 19,729 | 0 | 0 | 0 | For |
| Brighthouse | 19,319 | 0 | 0 | 0 | For |
| AQR | 19,191 | 0 | 0 | 0 | For |
| Victory Capital | 18,762 | 0 | 0 | 0 | For |
Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: To elect six director nominees to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Sharmila Dissanaike, M.D., FACS, FCCM
HERON THERAPEUTICS INC.’s own tally for this item (“Elect Director: Dr. Dissanaike”): 86,622,579 for, 875,337 against, per its Form 8-K filed June 18, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 42 asset managers below reported 12,561,961 for, 48,413 against, 34,692 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,357,334 | 0 | 0 | 0 | For |
| BlackRock | 2,600,053 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,632,692 | 0 | 0 | 0 | For |
| State Street | 582,775 | 0 | 0 | 0 | For |
| Charles Schwab | 502,940 | 0 | 0 | 0 | For |
| Equitable | 274,608 | 0 | 0 | 0 | For |
| SEI | 240,911 | 0 | 0 | 0 | For |
| HIGHLAND GLOBAL ALLOCATION FUND | 232,800 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 224,108 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 185,313 | 0 | 0 | 0 | For |
| Lincoln Financial | 134,700 | 0 | 0 | 0 | For |
| TIAA | 116,628 | 0 | 0 | 0 | For |
| Fidelity | 93,989 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 47,993 | 0 | 0 | Against |
| Northern Trust | 46,803 | 0 | 0 | 0 | For |
| Zacks Trust | 41,348 | 0 | 0 | 0 | For |
| AuguStar | 0 | 0 | 34,692 | 0 | Abstain |
| Pacific Life | 33,105 | 0 | 0 | 0 | For |
| Voya | 32,333 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,518 | 0 | 0 | 0 | For |
| Legg Mason | 21,926 | 0 | 0 | 0 | For |
| John Hancock | 19,729 | 0 | 0 | 0 | For |
| Brighthouse | 19,319 | 0 | 0 | 0 | For |
| AQR | 19,191 | 0 | 0 | 0 | For |
| Victory Capital | 18,762 | 0 | 0 | 0 | For |
Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: To elect six director nominees to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Susan Rodriguez
HERON THERAPEUTICS INC.’s own tally for this item (“Elect Director: Ms. Rodriguez”): 86,593,635 for, 879,793 against, per its Form 8-K filed June 18, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 42 asset managers below reported 12,561,961 for, 48,413 against, 34,692 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,357,334 | 0 | 0 | 0 | For |
| BlackRock | 2,600,053 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,632,692 | 0 | 0 | 0 | For |
| State Street | 582,775 | 0 | 0 | 0 | For |
| Charles Schwab | 502,940 | 0 | 0 | 0 | For |
| Equitable | 274,608 | 0 | 0 | 0 | For |
| SEI | 240,911 | 0 | 0 | 0 | For |
| HIGHLAND GLOBAL ALLOCATION FUND | 232,800 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 224,108 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 185,313 | 0 | 0 | 0 | For |
| Lincoln Financial | 134,700 | 0 | 0 | 0 | For |
| TIAA | 116,628 | 0 | 0 | 0 | For |
| Fidelity | 93,989 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 47,993 | 0 | 0 | Against |
| Northern Trust | 46,803 | 0 | 0 | 0 | For |
| Zacks Trust | 41,348 | 0 | 0 | 0 | For |
| AuguStar | 0 | 0 | 34,692 | 0 | Abstain |
| Pacific Life | 33,105 | 0 | 0 | 0 | For |
| Voya | 32,333 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,518 | 0 | 0 | 0 | For |
| Legg Mason | 21,926 | 0 | 0 | 0 | For |
| John Hancock | 19,729 | 0 | 0 | 0 | For |
| Brighthouse | 19,319 | 0 | 0 | 0 | For |
| AQR | 19,191 | 0 | 0 | 0 | For |
| Victory Capital | 18,762 | 0 | 0 | 0 | For |
Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).
90% Majority: yes · of votes cast
Description as filed by funds: TO AMEND THE COMPANY'S CERTIFICATE OF INCORPORATION TO INCREASE THE AGGREGATE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK BY 175,000,000 FROM 225,000,000 TO 400,000,000.
HERON THERAPEUTICS INC.’s own tally for this item (“4. Amendment to the Company's Certificate of Incorporation, as amended, to increase the aggregate number of authorized shares of the Company's common stock by 175,000,000 from 225,000,000 to 400,000,000”): 104,392,527 for, 11,372,028 against, per its Form 8-K filed June 18, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 42 asset managers below reported 12,548,714 for, 96,352 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,357,334 | 0 | 0 | 0 | For |
| BlackRock | 2,600,053 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,632,692 | 0 | 0 | 0 | For |
| State Street | 582,775 | 0 | 0 | 0 | For |
| Charles Schwab | 502,940 | 0 | 0 | 0 | For |
| Equitable | 274,608 | 0 | 0 | 0 | For |
| SEI | 240,911 | 0 | 0 | 0 | For |
| HIGHLAND GLOBAL ALLOCATION FUND | 232,800 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 162,448 | 61,660 | 0 | 0 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 185,313 | 0 | 0 | 0 | For |
| Lincoln Financial | 134,700 | 0 | 0 | 0 | For |
| TIAA | 116,628 | 0 | 0 | 0 | For |
| Fidelity | 93,989 | 0 | 0 | 0 | For |
| Federated Hermes | 47,993 | 0 | 0 | 0 | For |
| Northern Trust | 46,803 | 0 | 0 | 0 | For |
| Zacks Trust | 41,348 | 0 | 0 | 0 | For |
| AuguStar | 0 | 34,692 | 0 | 0 | Against |
| Pacific Life | 33,105 | 0 | 0 | 0 | For |
| Voya | 32,333 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,518 | 0 | 0 | 0 | For |
| Legg Mason | 21,926 | 0 | 0 | 0 | For |
| John Hancock | 19,729 | 0 | 0 | 0 | For |
| Brighthouse | 19,319 | 0 | 0 | 0 | For |
| AQR | 19,191 | 0 | 0 | 0 | For |
| Victory Capital | 18,762 | 0 | 0 | 0 | For |
Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: TO AMEND THE ESPP TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE THEREUNDER BY 1,200,000 FROM 2,225,000 TO 3,425,000.
HERON THERAPEUTICS INC.’s own tally for this item (“6. Amendment to the Company's 1997 Employee Stock Purchase Plan, as amended, to increase the number of shares of the Company's common stock authorized for issuance thereunder by 1,200,000 from 2,225,000 to 3,425,000”): 82,707,274 for, 5,000,632 against, per its Form 8-K filed June 18, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 43 asset managers below reported 12,588,876 for, 96,352 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,357,334 | 0 | 0 | 0 | For |
| BlackRock | 2,600,053 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,632,692 | 0 | 0 | 0 | For |
| State Street | 582,775 | 0 | 0 | 0 | For |
| Charles Schwab | 502,940 | 0 | 0 | 0 | For |
| Equitable | 274,608 | 0 | 0 | 0 | For |
| SEI | 240,911 | 0 | 0 | 0 | For |
| HIGHLAND GLOBAL ALLOCATION FUND | 232,800 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 162,448 | 61,660 | 0 | 0 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 185,313 | 0 | 0 | 0 | For |
| Lincoln Financial | 134,700 | 0 | 0 | 0 | For |
| TIAA | 116,628 | 0 | 0 | 0 | For |
| Fidelity | 93,989 | 0 | 0 | 0 | For |
| Federated Hermes | 47,993 | 0 | 0 | 0 | For |
| Northern Trust | 46,803 | 0 | 0 | 0 | For |
| Zacks Trust | 41,348 | 0 | 0 | 0 | For |
| GRIMES & COMPANY, INC. | 40,162 | 0 | 0 | 0 | For |
| AuguStar | 0 | 34,692 | 0 | 0 | Against |
| Pacific Life | 33,105 | 0 | 0 | 0 | For |
| Voya | 32,333 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,518 | 0 | 0 | 0 | For |
| Legg Mason | 21,926 | 0 | 0 | 0 | For |
| John Hancock | 19,729 | 0 | 0 | 0 | For |
| Brighthouse | 19,319 | 0 | 0 | 0 | For |
| AQR | 19,191 | 0 | 0 | 0 | For |
Showing the 25 largest of 43 asset managers. All 43 are in the interactive database (link above).
72% Majority: yes · of votes cast
Prior year: 79.0% for (June 6, 2023 meeting) ▼ 7.0 pts
Description as filed by funds: TO AMEND THE 2007 PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE THEREUNDER BY 7,500,000 FROM 39,190,000 TO 46,690,000.
HERON THERAPEUTICS INC.’s own tally for this item (“5. Amendment to the Company's 2007 Amended and Restated Equity Incentive Plan to increase the number of shares of the Company's common stock authorized for issuance thereunder by 7,500,000 from 39,190,000 to 46,690,000”): 62,949,448 for, 24,467,411 against, per its Form 8-K filed June 18, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 72% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 42 asset managers below reported 10,944,463 for, 1,665,911 against, 34,692 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,357,334 | 0 | 0 | 0 | For |
| BlackRock | 2,600,053 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,632,692 | 0 | 0 | 0 | For |
| State Street | 0 | 582,775 | 0 | 0 | Against |
| Charles Schwab | 502,940 | 0 | 0 | 0 | For |
| Equitable | 109,578 | 165,030 | 0 | 0 | Mixed |
| SEI | 240,911 | 0 | 0 | 0 | For |
| HIGHLAND GLOBAL ALLOCATION FUND | 0 | 232,800 | 0 | 0 | Against |
| Jacob Funds Inc. | 162,448 | 61,660 | 0 | 0 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 185,313 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 134,700 | 0 | 0 | Against |
| TIAA | 0 | 116,628 | 0 | 0 | Against |
| Fidelity | 0 | 93,989 | 0 | 0 | Against |
| Federated Hermes | 47,993 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 46,803 | 0 | 0 | Against |
| Zacks Trust | 41,348 | 0 | 0 | 0 | For |
| AuguStar | 0 | 0 | 34,692 | 0 | Abstain |
| Pacific Life | 33,105 | 0 | 0 | 0 | For |
| Voya | 0 | 32,333 | 0 | 0 | Against |
| Bridge Builder Trust | 24,518 | 0 | 0 | 0 | For |
| Legg Mason | 0 | 21,926 | 0 | 0 | Against |
| John Hancock | 0 | 19,729 | 0 | 0 | Against |
| Brighthouse | 0 | 19,319 | 0 | 0 | Against |
| AQR | 0 | 19,191 | 0 | 0 | Against |
| Victory Capital | 0 | 18,762 | 0 | 0 | Against |
Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
83% Majority: yes · of votes cast
Prior year: 97.6% for (June 6, 2023 meeting) ▼ 14.1 pts
Description as filed by funds: TO APPROVE, ON A NONBINDING ADVISORY BASIS, COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS DURING THE FISCAL YEAR ENDED DECEMBER 31, 2023.
HERON THERAPEUTICS INC.’s own tally for this item (“3. Nonbinding advisory vote to approve compensation paid to the Company's Named Executive Officers during the year ended December 31, 2023”): 72,711,988 for, 14,427,205 against, per its Form 8-K filed June 18, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,357,334 | 0 | 0 | 0 | For |
| BlackRock | 2,600,053 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,632,692 | 0 | 0 | 0 | For |
| State Street | 582,775 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 502,940 | 0 | 0 | Against |
| Equitable | 274,608 | 0 | 0 | 0 | For |
| SEI | 0 | 240,911 | 0 | 0 | Against |
| HIGHLAND GLOBAL ALLOCATION FUND | 0 | 232,800 | 0 | 0 | Against |
| Jacob Funds Inc. | 224,108 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 185,313 | 0 | 0 | 0 | For |
| Lincoln Financial | 134,700 | 0 | 0 | 0 | For |
| TIAA | 116,628 | 0 | 0 | 0 | For |
| Fidelity | 93,989 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 47,993 | 0 | 0 | Against |
| Northern Trust | 46,803 | 0 | 0 | 0 | For |
| Zacks Trust | 41,348 | 0 | 0 | 0 | For |
| AuguStar | 0 | 0 | 34,692 | 0 | Abstain |
| Pacific Life | 33,105 | 0 | 0 | 0 | For |
| Voya | 32,333 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,518 | 0 | 0 | 0 | For |
| Legg Mason | 21,926 | 0 | 0 | 0 | For |
| John Hancock | 19,729 | 0 | 0 | 0 | For |
| Brighthouse | 19,319 | 0 | 0 | 0 | For |
| AQR | 19,191 | 0 | 0 | 0 | For |
| Victory Capital | 18,762 | 0 | 0 | 0 | For |
Fund voting reports, all 42 managers: 11,576,587 for, 1,033,787 against, 34,692 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 26,713,503 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 0 | 8,268,036 | 0 | 0 | Against |
| Velan Capital Investment Management LP | 6,986,744 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 4,902,703 | 0 | 0 | 0 | For |
| BlackRock | 2,634,412 | 0 | 0 | 0 | For |
| PALISADE CAPITAL MANAGEMENT, LP | 2,292,694 | 0 | 0 | 0 | For |
| JW Asset Management, LLC | 0 | 0 | 0 | 0 | -- |
| Orchard Capital Management, LLC | 0 | 0 | 0 | 2,018,126 | Withhold |
| Clearline Capital LP | 1,747,533 | 0 | 0 | 0 | For |
| State Street | 1,734,998 | 0 | 0 | 0 | For |
| Monaco Asset Management SAM | 0 | 0 | 1,683,164 | 0 | Abstain |
| NEW YORK STATE COMMON RETIREMENT FUND | 0 | 1,094,219 | 0 | 0 | Against |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 936,418 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 502,940 | 0 | 0 | Against |
| Northern Trust | 459,734 | 126 | 0 | 0 | For |
| DE Shaw | 420,954 | 0 | 0 | 0 | For |
| Renaissance | 410,346 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 388,983 | 0 | 0 | 0 | For |
| Wellington | 0 | 374,702 | 0 | 0 | Against |
| Goldman Sachs | 254,623 | 0 | 0 | 0 | For |
| SEI | 0 | 241,411 | 0 | 0 | Against |
| Citadel | 197,394 | 0 | 0 | 0 | For |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 170,409 | 0 | 0 | 0 | For |
| AllianceBernstein | 165,030 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0 | 163,823 | 0 | 0 | Against |
Institutional-manager reports, all 132 managers: 52,007,694 for, 11,034,303 against, 2,018,126 withheld, 1,683,164 abstained, 2,292,418 unknown. Showing the 25 largest; every one is in the interactive database (link above).
99.7% Majority: yes · of votes cast
Prior year: 99.6% for (June 6, 2023 meeting) ▲ 0.1 pts
Description as filed by funds: TO RATIFY THE APPOINTMENT OF WITHUM AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024.
HERON THERAPEUTICS INC.’s own tally for this item (“2. Ratification of the appointment of Withum Smith+Brown, PC as the Company's independent registered public accounting firm for the year ending December 31, 2024”): 114,364,367 for, 358,527 against, per its Form 8-K filed June 18, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 42 asset managers below reported 12,610,374 for, 34,692 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,357,334 | 0 | 0 | 0 | For |
| BlackRock | 2,600,053 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 1,632,692 | 0 | 0 | 0 | For |
| State Street | 582,775 | 0 | 0 | 0 | For |
| Charles Schwab | 502,940 | 0 | 0 | 0 | For |
| Equitable | 274,608 | 0 | 0 | 0 | For |
| SEI | 240,911 | 0 | 0 | 0 | For |
| HIGHLAND GLOBAL ALLOCATION FUND | 232,800 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 224,108 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 185,313 | 0 | 0 | 0 | For |
| Lincoln Financial | 134,700 | 0 | 0 | 0 | For |
| TIAA | 116,628 | 0 | 0 | 0 | For |
| Fidelity | 93,989 | 0 | 0 | 0 | For |
| Federated Hermes | 47,993 | 0 | 0 | 0 | For |
| Northern Trust | 46,803 | 0 | 0 | 0 | For |
| Zacks Trust | 41,348 | 0 | 0 | 0 | For |
| AuguStar | 0 | 0 | 34,692 | 0 | Abstain |
| Pacific Life | 33,105 | 0 | 0 | 0 | For |
| Voya | 32,333 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,518 | 0 | 0 | 0 | For |
| Legg Mason | 21,926 | 0 | 0 | 0 | For |
| John Hancock | 19,729 | 0 | 0 | 0 | For |
| Brighthouse | 19,319 | 0 | 0 | 0 | For |
| AQR | 19,191 | 0 | 0 | 0 | For |
| Victory Capital | 18,762 | 0 | 0 | 0 | For |
Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 150,653,158 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 3.56% |
| 2 | BlackRock | 1.73% |
| 3 | FRANKLIN STRATEGIC SERIES | 1.08% |
| 4 | State Street | 0.39% |
| 5 | Charles Schwab | 0.33% |
| 6 | Equitable | 0.18% |
| 7 | SEI | 0.16% |
| 8 | HIGHLAND GLOBAL ALLOCATION FUND | 0.15% |
| 9 | Jacob Funds Inc. | 0.15% |
| 10 | QUANTITATIVE MASTER SERIES LLC | 0.12% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Rubric Capital Management LP | 17.73% |
| 2 | ORBIMED ADVISORS LLC | 5.49% |
| 3 | Velan Capital Investment Management LP | 4.64% |
| 4 | FRANKLIN ADVISERS INC | 3.25% |
| 5 | BlackRock | 1.75% |
| 6 | PALISADE CAPITAL MANAGEMENT, LP | 1.52% |
| 7 | JW Asset Management, LLC | 1.52% |
| 8 | Orchard Capital Management, LLC | 1.34% |
| 9 | Clearline Capital LP | 1.16% |
| 10 | State Street | 1.15% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Rubric Capital Management LP | 26,713,503 | 17.73% | Proxy statement (DEF 14A), proxy filed April 29, 2024 |
| BlackRock | 9,987,460 | 6.63% | Form 13F, quarter ended March 31, 2024 |
| Vanguard Group | 8,459,784 | 5.62% | Form 13F, quarter ended March 31, 2024 |
| Adam Morgan | 7,080,026 | 4.70% | Proxy statement (DEF 14A), proxy filed April 29, 2024 |
| Franklin Templeton | 6,374,584 | 4.23% | Form 13F, quarter ended March 31, 2024 |
| Geode Capital | 2,796,119 | 1.86% | Form 13F, quarter ended March 31, 2024 |
| D.E. Shaw | 2,695,046 | 1.79% | Form 13F, quarter ended March 31, 2024 |
| State Street | 2,440,870 | 1.62% | Form 13F, quarter ended March 31, 2024 |
| Renaissance Technologies | 2,406,486 | 1.60% | Form 13F, quarter ended March 31, 2024 |
| Goldman Sachs | 1,324,802 | 0.88% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 150,653,158 shares outstanding, as reported by HERON THERAPEUTICS INC. on its Form 10-Q dated May 2, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At HERON THERAPEUTICS INC.'s shareholder meeting held June 13, 2024, in the 2023-2024 proxy season, 160 asset managers reported votes on at least one of its 11 ballot items in their SEC Form N-PX filings, covering 1,473 separate fund positions. On the most widely held item on that ballot — TO APPROVE, ON A NONBINDING ADVISORY BASIS, COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS… — FOR was 83% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: HERON THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 18, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from HERON THERAPEUTICS INC.’s 10-Q dated May 2, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
HERON THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “HERON THERAPEUTICS (HRTX) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/heron-therapeutics-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.